carbidopa has been researched along with Adenocarcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, H; Fazli, L; Gleave, ME; Lamoureux, F; Rennie, PS; Thomas, C; Wafa, LA | 1 |
Aramendi, T; Argente, J; Cabranes, JA; Calle-Pascual, AL; Catalan, MJ; Charro, AL; Garcia-MauriƱo, ML; Martin, P; Uria, J; Yuste, E | 1 |
2 other study(ies) available for carbidopa and Adenocarcinoma
Article | Year |
---|---|
Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor-axis in castration-resistant prostate tumors.
Topics: Adenocarcinoma; Anilides; Animals; Antineoplastic Agents; Apoptosis; Carbidopa; Cell Line, Tumor; Cell Survival; Disease Progression; Dopamine Agents; Drug Synergism; Drug Therapy, Combination; Humans; In Vitro Techniques; Male; Mice; Mice, Nude; Nitriles; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Tosyl Compounds; Treatment Outcome; Xenograft Model Antitumor Assays | 2012 |
Association of a thyrotropin-secreting pituitary adenoma and a thyroid follicular carcinoma.
Topics: Adenocarcinoma; Adenoma; Brain; Carbidopa; Drug Therapy, Combination; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hydrocortisone; Insulin; Levodopa; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Radioimmunoassay; Thyroid Neoplasms; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Tomography, X-Ray Computed; Triiodothyronine | 1991 |